ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

NGM NGM Biopharmaceuticals Inc

1.54
0.00 (0.00%)
Jun 13 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NGM Biopharmaceuticals Inc NGM NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.54 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.54 1.54
more quote information »

Recent News

Date Time Source Heading
4/05/202408:19GLOBENGM Bio Announces Closing of Tender Offer
3/19/202416:30GLOBENGM Bio to Present Two Posters Highlighting Clinical Data..
3/11/202415:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/11/202415:13EDGAR2Form 8-K - Current report
3/11/202415:05GLOBENGM Bio Provides Recent Business Highlights and Reports..
3/08/202416:32EDGAR2Form SC 13E3 - Going private transaction by certain issuers
3/08/202416:21EDGAR2Form SC 14D9 - Solicitation, recommendation statements
2/26/202416:11EDGAR2Form SC14D9C - Written communication relating to third party..
2/26/202416:01EDGAR2Form 8-K - Current report
2/26/202408:03GLOBENGM Bio Has Entered into a Definitive Agreement and Plan of..
2/20/202415:01GLOBENGM Bio to Participate in the Cowen 44th Annual Health Care..
2/14/202417:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/22/202405:09EDGAR2Form 8-K - Current report
1/18/202417:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/18/202417:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/17/202415:47GLOBENGM Bio to Participate in the B. Riley Securities 4th Annual..
1/09/202407:00GLOBENGM Bio Announces New Clinical Data from Ongoing Trial of..
1/02/202406:30EDGAR2Form 8-K - Current report
12/04/202316:19EDGAR2Form 8-K - Current report
12/04/202315:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202308:45GLOBENGM Bio Presents Positive Phase 2b Results from the ALPINE 4..
11/08/202317:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/08/202317:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202317:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202317:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202315:05GLOBENGM Bio to Participate in Upcoming Investor Conferences
11/02/202315:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202315:06EDGAR2Form 8-K - Current report
11/02/202315:01GLOBENGM Bio Reports Third Quarter 2023 Financial Results and..
10/17/202316:28EDGAR2Form 8-K - Current report
10/11/202315:05GLOBENGM Bio Announces Oral Plenary Presentation of Data from..
9/27/202307:30PRNUSAlexandria Real Estate Equities, Inc.'s One-of-a-Kind,..
9/11/202315:01EDGAR2Form 8-K/A - Current report: [Amend]
8/11/202315:08EDGAR2Form 8-K - Current report
8/06/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
8/04/202316:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
8/04/202315:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
8/03/202315:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/03/202315:07EDGAR2Form 8-K - Current report
8/03/202315:01GLOBENGM Bio Reports Second Quarter 2023 Financial Results and..

Your Recent History

Delayed Upgrade Clock